Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Deloitte
Mallinckrodt
Chinese Patent Office
Merck
Harvard Business School
McKesson
McKinsey
Medtronic
Colorcon

Generated: August 23, 2017

DrugPatentWatch Database Preview

Masoprocol - Generic Drug Details

« Back to Dashboard

What are the generic sources for masoprocol and what is the scope of masoprocol patent protection?

Masoprocol
is the generic ingredient in one branded drug marketed by Univ Az Cancer Ctr and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for masoprocol.

Summary for Generic Name: masoprocol

Tradenames:1
Patents:0
Applicants:1
NDAs:1
Drug Master File Entries: see list1
Bulk Api Vendors: see list29
Clinical Trials: see list1
Patent Applications: see list8,479
Drug Prices:see low prices
DailyMed Link:masoprocol at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Univ Az Cancer Ctr
ACTINEX
masoprocol
CREAM;TOPICAL019940-001Sep 4, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: masoprocol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Univ Az Cancer Ctr
ACTINEX
masoprocol
CREAM;TOPICAL019940-001Sep 4, 1992► Subscribe► Subscribe
Univ Az Cancer Ctr
ACTINEX
masoprocol
CREAM;TOPICAL019940-001Sep 4, 1992► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Novartis
Deloitte
Harvard Business School
McKesson
UBS
Julphar
Federal Trade Commission
Baxter
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot